Variant report

Variant	nsv962237
Chromosome Location	chr17:45503835-45518835
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:46)
CpG islands
(count:61)
Chromatin interactive
region (count:2)
LncRNA
region (count:0)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:46 , 50 per page) page: 1

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ARID3A	chr17:45505316-45506040	HepG2	liver:	n/a	n/a
2	BCL11A	chr17:45504891-45505246	GM12878	blood:	n/a	n/a
3	CEBPB	chr17:45505310-45505563	HepG2	liver:	n/a	n/a
4	CTCF	chr17:45513628-45513693	Lung_OC	lung:	n/a	n/a
5	CTCF	chr17:45503813-45503939	Spleen_OC	spleen:	n/a	n/a
6	CTCF	chr17:45507446-45507452	A549	lung:	n/a	n/a
7	FOS	chr17:45504969-45505211	MCF10A-Er-Src	breast:	n/a	n/a
8	FOXA1	chr17:45505472-45505843	HepG2	liver:	n/a	chr17:45505656-45505671
9	FOXA1	chr17:45505310-45506043	HepG2	liver:	n/a	chr17:45505656-45505671
10	FOXA1	chr17:45505368-45506017	HepG2	liver:	n/a	chr17:45505656-45505671
11	FOXA1	chr17:45505163-45506137	HepG2	liver:	n/a	chr17:45505656-45505671
12	FOXA2	chr17:45505301-45505999	HepG2	liver:	n/a	n/a
13	FOXA2	chr17:45505038-45505955	HepG2	liver:	n/a	n/a
14	FOXA2	chr17:45505378-45505900	A549	lung:	n/a	n/a
15	GATA3	chr17:45511448-45511683	SH-SY5Y	brain:	n/a	n/a
16	HNF4A	chr17:45505239-45505773	HepG2	liver:	n/a	chr17:45505437-45505452 chr17:45505437-45505452 chr17:45505436-45505454 chr17:45505439-45505452 chr17:45505438-45505446 chr17:45505439-45505452
17	JUND	chr17:45504943-45505208	HepG2	liver:	n/a	chr17:45505091-45505102
18	KAP1	chr17:45517885-45518274	K562	blood:	n/a	n/a
19	MAFF	chr17:45513373-45513429	HepG2	liver:	n/a	n/a
20	MAFK	chr17:45508241-45508403	HepG2	liver:	n/a	n/a
21	POLR2A	chr17:45516770-45516775	A549	lung:	n/a	n/a
22	POLR2A	chr17:45503266-45503988	H1-hESC	embryonic stem cell:	n/a	n/a
23	POLR2A	chr17:45503358-45503839	Hela-S3	cervix:	n/a	n/a
24	POLR2A	chr17:45502573-45503928	GM12892	blood:	n/a	n/a
25	POLR2A	chr17:45503235-45503872	H1-hESC	embryonic stem cell:	n/a	n/a
26	POLR2A	chr17:45507424-45507467	MCF-7	breast:	n/a	n/a
27	POLR2A	chr17:45503841-45503940	Hela-S3	cervix:	n/a	n/a
28	POLR2A	chr17:45502438-45503925	GM12892	blood:	n/a	n/a
29	POLR2A	chr17:45502995-45503922	GM12891	blood:	n/a	n/a
30	POLR2A	chr17:45508310-45508472	MCF10A-Er-Src	breast:	n/a	n/a
31	POLR2A	chr17:45502453-45503935	GM12878	blood:	n/a	n/a
32	POLR2A	chr17:45507381-45507581	A549	lung:	n/a	n/a
33	POLR2A	chr17:45503150-45503877	GM12891	blood:	n/a	n/a
34	POLR2A	chr17:45503153-45503850	GM12892	blood:	n/a	n/a
35	RFX5	chr17:45518288-45518549	HepG2	liver:	n/a	chr17:45518439-45518454
36	RFX5	chr17:45518340-45518513	Hela-S3	cervix:	n/a	chr17:45518439-45518454
37	SETDB1	chr17:45511834-45512197	U2OS	brain:	n/a	n/a
38	SIN3AK20	chr17:45505533-45505717	HepG2	liver:	n/a	n/a
39	SP1	chr17:45505219-45505779	HepG2	liver:	n/a	n/a
40	SPI1	chr17:45512931-45513224	GM12878	blood:	n/a	n/a
41	SPI1	chr17:45512930-45513259	GM12891	blood:	n/a	n/a
42	SPI1	chr17:45512947-45513237	GM12891	blood:	n/a	n/a
43	STAT3	chr17:45505873-45505885	MCF10A-Er-Src	breast:	n/a	n/a
44	TCF7L2	chr17:45517471-45517839	HepG2	liver:	n/a	n/a
45	ZC3H11A	chr17:45509674-45509869	K562	blood:	n/a	n/a
46	ZNF384	chr17:45510945-45510988	GM12878	blood:	n/a	n/a

(count:61 , 50 per page) page: 1 2

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr17:45505249-45505299	PANC-1	pancreas:	n/a
2	chr17:45505249-45505299	NHBE	bronchial:	n/a
3	chr17:45505249-45505299	HCT-116	colon:	n/a
4	chr17:45505249-45505299	PrEC	prostate:	n/a
5	chr17:45505249-45505299	AG09319	gingival:	n/a
6	chr17:45505249-45505299	Caco-2	colon:	n/a
7	chr17:45505249-45505299	AG04449	skin:	fetal
8	chr17:45505249-45505299	HMEC	breast:	n/a
9	chr17:45505249-45505299	H1-hESC	embryonic stem cell:	embryo
10	chr17:45505249-45505299	SAEC	small airway:	n/a
11	chr17:45505249-45505299	SK-N-SH_RA	brain:	n/a
12	chr17:45505249-45505299	HepG2	liver:	n/a
13	chr17:45505249-45505299	HCF	heart:	n/a
14	chr17:45505249-45505299	MCF-7	breast:	n/a
15	chr17:45505249-45505299	HIPEpiC	eye:	n/a
16	chr17:45505249-45505299	BJ	skin:	n/a
17	chr17:45505249-45505299	NT2-D1	testis:	n/a
18	chr17:45505249-45505299	AoSMC	blood vessel:	n/a
19	chr17:45505249-45505299	HEK293	kidney:	embryo
20	chr17:45505249-45505299	HUVEC	blood vessel:	n/a
21	chr17:45505249-45505299	BE2_C	brain:	n/a
22	chr17:45505249-45505299	HCM	heart:	n/a
23	chr17:45505249-45505299	LNCaP	prostate:	n/a
24	chr17:45505249-45505299	Jurkat	blood:	n/a
25	chr17:45505249-45505299	AG10803	skin:	n/a
26	chr17:45505249-45505299	AG09309	skin:	n/a
27	chr17:45505249-45505299	SKMC	muscle:	n/a
28	chr17:45505249-45505299	HRPEpiC	eye:	n/a
29	chr17:45505249-45505299	MCF10A-Er-Src	breast:	n/a
30	chr17:45505249-45505299	U87	brain:	n/a
31	chr17:45505249-45505299	AG04450	lung:	fetal
32	chr17:45505249-45505299	A549	lung:	n/a
33	chr17:45505249-45505299	NHDF-neo	bronchial:	n/a
34	chr17:45505249-45505299	ProgFib	skin:	n/a
35	chr17:45505249-45505299	ovcar-3	ovarian:	n/a
36	chr17:45505249-45505299	HNPCEpiC	eye:	n/a
37	chr17:45505249-45505299	NH-A	brain:	n/a
38	chr17:45505249-45505299	HEEpiC	esophagus:	n/a
39	chr17:45505249-45505299	HPAEpiC	pulmonary alveolar:	n/a
40	chr17:45505249-45505299	T-47D	breast:	n/a
41	chr17:45505249-45505299	HL-60	blood:	n/a
42	chr17:45505249-45505299	HAEpiC	amniotic membrane:	n/a
43	chr17:45505249-45505299	CMK	blood:	n/a
44	chr17:45505249-45505299	NB4	blood:	n/a
45	chr17:45505249-45505299	GM12892	blood:	n/a
46	chr17:45505249-45505299	K562	blood:	n/a
47	chr17:45505249-45505299	SK-N-SH	brain:	n/a
48	chr17:45505249-45505299	Hepatocyte	liver:	n/a
49	chr17:45505249-45505299	GM12878	blood:	n/a
50	chr17:45505249-45505299	HRE	kidney:	n/a

(count:2 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type	Cell Stage
1	chr17:45499733..45501782-chr17:45502052..45504438,2	K562	blood:
2	chr17:45450230..45451965-chr17:45515633..45517209,2	K562	blood:

No data

Variant related genes	Relation type
ENSG00000253347	TF binding region
ENSG00000253347	CpG island
ENSG00000253347	chromatin interactions

Extended variants
information (count: 464 )
Associated
traits (count: 118 )

Variant overlapped rSNPs/rCNVs (count:464 , 50 per page) page: 1 2 3 4 5 6 7 ... 10

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs542101131	chr17:45503844-45503845	Weak transcription	TF binding region Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
2	rs561770859	chr17:45503921-45503922	Weak transcription	TF binding region Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
3	rs372430739	chr17:45503948-45503949	Weak transcription	TF binding region Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
4	rs530699631	chr17:45503994-45503995	Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
5	rs544402199	chr17:45504001-45504002	Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
6	rs7222354	chr17:45504024-45504025	Weak transcription	Chromatin interactive region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
7	rs141686063	chr17:45504128-45504129	Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
8	rs547058985	chr17:45504167-45504168	Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
9	rs566869064	chr17:45504249-45504250	Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
10	rs183982001	chr17:45504273-45504274	Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
11	rs558709757	chr17:45504348-45504349	Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
12	rs549636120	chr17:45504413-45504414	Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
13	rs569366444	chr17:45504441-45504442	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
14	rs143834240	chr17:45504481-45504482	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
15	rs538404969	chr17:45504531-45504532	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
16	rs7223254	chr17:45504559-45504560	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
17	rs75362796	chr17:45504567-45504568	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
18	rs147064263	chr17:45504641-45504642	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
19	rs188078703	chr17:45504675-45504676	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
20	rs539134264	chr17:45504686-45504687	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
21	rs552595112	chr17:45504752-45504753	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
22	rs572784428	chr17:45504816-45504817	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
23	rs541776957	chr17:45504838-45504839	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
24	rs10514929	chr17:45504870-45504871	Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
25	rs190602555	chr17:45504903-45504904	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
26	rs544355868	chr17:45505005-45505006	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
27	rs564265907	chr17:45505152-45505153	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
28	rs115918889	chr17:45505182-45505183	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
29	rs4386181	chr17:45505194-45505195	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
30	rs560505949	chr17:45505249-45505250	Weak transcription Enhancers	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
31	rs72829640	chr17:45505279-45505280	Weak transcription Enhancers	TF binding region CpG island	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
32	rs113361100	chr17:45505291-45505292	Weak transcription Enhancers	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
33	rs73985163	chr17:45505354-45505355	Weak transcription Enhancers	TF binding region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
34	rs371033235	chr17:45505366-45505367	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
35	rs569487357	chr17:45505414-45505415	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
36	rs531819281	chr17:45505452-45505453	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
37	rs112959227	chr17:45505494-45505495	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
38	rs530708388	chr17:45505520-45505521	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
39	rs182890188	chr17:45505581-45505582	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
40	rs551598659	chr17:45505631-45505632	Weak transcription Enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
41	rs571501666	chr17:45505650-45505651	Weak transcription Enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
42	rs144825891	chr17:45505689-45505690	Weak transcription Enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
43	rs201653057	chr17:45505691-45505692	Weak transcription Enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
44	rs199945548	chr17:45505694-45505695	Weak transcription Enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
45	rs77489465	chr17:45505768-45505769	Weak transcription Enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
46	rs552618451	chr17:45505784-45505785	Weak transcription Enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
47	rs141849491	chr17:45505854-45505855	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
48	rs75331046	chr17:45505856-45505857	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
49	rs150163295	chr17:45505864-45505865	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
50	rs575536294	chr17:45505911-45505912	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:118)

Disease	PMID	Source
Ewing''s sarcoma	21437220	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Glioblastoma multiforme	21080181	CNVD
Ovarian cancer	22174824	CNVD
Melanoma	18172304	CNVD
Moyamoya disease	22323933	CNVD
Oral squamous cell carcinoma	17134496	CNVD
Ovarian cancer	21781307	CNVD
Colorectal cancer	21645411	CNVD
Breast cancer	20668451	CNVD
Cancer	20668451	CNVD
Lung cancer	20668451	CNVD
Ovarian cancer	20668451	CNVD
Pancreas cancer	20668451	CNVD
Prostate cancer	20668451	CNVD
Medulloblastoma	21979893	CNVD
Cancer	20164919	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Hodgkin''s lymphoma	17606441	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Acute myeloid leukemia	20729466	CNVD
T-cell lymphomas	19863542	CNVD
Cancer	16751803	CNVD
Chordoma	21602918	CNVD
Neurofibromatosis	20686819	CNVD
Peripheral nerve sheath tumors	20686819	CNVD
Splenic marginal zone lymphoma	21957467	CNVD
Cancer	21499728	CNVD
Glioblastoma multiforme	19960244	CNVD
Hepatocellular carcinoma	22174799	CNVD
Medulloblastoma	21292688	CNVD
Neuroblastoma	18923524	CNVD
Neuroblastoma	17897457	CNVD
Neuroblastoma	17327916	CNVD
Breast cancer	21264507	CNVD
Endometrial cancer	22040021	CNVD
Neuroblastoma	21484798	CNVD
Breast cancer	22028636	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Acute myeloid leukemia	20724749	CNVD
Breast cancer	21858162	CNVD
lymphocytic leukemia	21291569	CNVD
Gastric cancer	17167181	CNVD
Breast cancer	19287154	CNVD
Leukemia	20874852	CNVD
Adenoid cystic carcinoma	17372589	CNVD
Neuroblastoma	18664255	CNVD
Neuroblastoma	17533364	CNVD
Human rectal carcinomas	16397240	CNVD
Metanephric adenoma	20802469	CNVD
Breast cancer	16608533	CNVD
Breast cancer	17457667	CNVD
Breast cancer	16951389	CNVD
Basal cell lymphoma	17053054	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
small cell lung cancer	20016488	CNVD
Breast cancer	22048815	CNVD
Breast cancer	17603634	CNVD
Follicular lymphoma	20505157	CNVD
Non-small cell lung cancer	20864512	CNVD
Cancer	21183584	CNVD
Cervical cancer	21062161	CNVD
Breast cancer	20953835	CNVD
Thyroid cancer	19087340	CNVD
Acute lymphoblastic leukemia	17443227	CNVD
Hirschsprung''s Disease	21712996	CNVD
Non-syndromic sensorineural hearing loss	15273396	CNVD
TAR Syndrome	17847015	CNVD
Neuroblastoma	18923191	CNVD
Breast cancer	17850661	CNVD
Breast cancer	19261255	CNVD
Lung cancer	16773561	CNVD
Neurocytoma	17123091	CNVD
Central neurocytomas	17123091	CNVD
Basal-like breast cancer	18066063	CNVD
Breast cancer	20031965	CNVD
Colorectal cancer	19287155	CNVD
Hereditary breast	19566914	CNVD
Ovarian cancer	19047089	CNVD
Ovarian cancer	19566914	CNVD
Triple-negative breast cancer	18950515	CNVD
Breast cancer	16846527	CNVD
Bladder cancer	21909424	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Biliary cancer	20360734	CNVD
Breast cancer	20360734	CNVD
Coronary artery disease	20360734	CNVD
Crohn''s disease	20360734	CNVD
Hypertension	20360734	CNVD
Rheumatoid arthritis	20360734	CNVD
Type 1 diabetes	20360734	CNVD
Type 2 diabetes	20360734	CNVD
T-cell prolymphocytic leukemia	17713554	CNVD
Ewing''s sarcoma	18628472	CNVD
Glioblastoma multiforme	18628472	CNVD
Leukemia	18628472	CNVD
Acute myeloid leukemia	21251322	CNVD
Ewing''s sarcoma	22429812	CNVD
Prostate cancer	18632612	CNVD
Lung cancer	18438408	CNVD
Breast cancer	21364760	CNVD
Urothelial carcinoma	21177765	CNVD
Breast cancer	16397240	CNVD
Ovarian clear cell carcinoma	19293255	CNVD
Myelofibrosis	22110671	CNVD
Prostate cancer	17217626	CNVD
Non-syndromic sensorineural hearing loss	21084979	CNVD
Autism	22817714	CNVD
Breast cancer	20409316	CNVD
Cancer	17160897	CNVD
Frontotemporal lobar degeneration	19640594	CNVD
Malignant mesothelioma	18160781	CNVD
Pleural malignant mesothelioma	18160781	CNVD
Ovarian clear cell carcinoma	21343371	CNVD
Breast cancer	21509527	CNVD
Breast cancer	22522925	CNVD
Pancreatic cancer	17952125	CNVD
Non-syndromic sensorineural hearing loss	22037309	CNVD

Chromatin state (count:117 , 50 per page) page: 1 2 3

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr17:45500600-45511200	Weak transcription	K562	blood
2	chr17:45500800-45506800	Weak transcription	Primary T killer naive cells fromperipheralblood	blood
3	chr17:45501400-45504800	Weak transcription	A549	lung
4	chr17:45501400-45514600	Weak transcription	Primary T cells from cord blood	blood
5	chr17:45501400-45554200	Weak transcription	Primary Natural Killer cells fromperipheralblood	blood
6	chr17:45501400-45554400	Weak transcription	Skeletal Muscle Female	skeletal muscle
7	chr17:45501600-45505600	Weak transcription	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
8	chr17:45501600-45509800	Weak transcription	Pancreas	Pancrea
9	chr17:45501600-45511400	Weak transcription	Esophagus	oesophagus
10	chr17:45501600-45511800	Weak transcription	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
11	chr17:45501600-45511800	Weak transcription	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
12	chr17:45501600-45515600	Weak transcription	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
13	chr17:45501600-45520200	Weak transcription	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
14	chr17:45501600-45555400	Weak transcription	Foreskin Fibroblast Primary Cells skin02	Skin
15	chr17:45501600-45556400	Weak transcription	Primary T helper cells PMA-I stimulated	--
16	chr17:45501800-45504600	Weak transcription	Skeletal Muscle Male	skeletal muscle
17	chr17:45501800-45504800	Weak transcription	Rectal Mucosa Donor 29	rectum
18	chr17:45501800-45505600	Weak transcription	Liver	Liver
19	chr17:45501800-45507800	Weak transcription	Primary T helper naive cells fromperipheralblood	blood
20	chr17:45501800-45508800	Weak transcription	Rectal Smooth Muscle	rectum
21	chr17:45501800-45511800	Weak transcription	Breast Myoepithelial Primary Cells	Breast
22	chr17:45501800-45511800	Weak transcription	Duodenum Smooth Muscle	Duodenum
23	chr17:45501800-45512400	Weak transcription	Primary B cells from cord blood	blood
24	chr17:45501800-45533400	Weak transcription	Gastric	stomach
25	chr17:45501800-45547400	Weak transcription	Fetal Muscle Trunk	muscle
26	chr17:45501800-45550200	Weak transcription	Ovary	ovary
27	chr17:45502000-45504600	Weak transcription	Pancreatic Islets	Pancreatic Islet
28	chr17:45502000-45505000	Weak transcription	Rectal Mucosa Donor 31	rectum
29	chr17:45502200-45504400	Weak transcription	Fetal Heart	heart
30	chr17:45502200-45504800	Weak transcription	Fetal Intestine Small	intestine
31	chr17:45502200-45506200	Weak transcription	Fetal Lung	lung
32	chr17:45502200-45513600	Weak transcription	Fetal Brain Male	brain
33	chr17:45502200-45548000	Weak transcription	H1 Derived Mesenchymal Stem Cells	ES cell derived
34	chr17:45502800-45548600	Weak transcription	Foreskin Fibroblast Primary Cells skin01	Skin
35	chr17:45503000-45512000	Weak transcription	Primary hematopoietic stem cells	blood
36	chr17:45503200-45510200	Weak transcription	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
37	chr17:45503200-45511800	Weak transcription	H9 Derived Neuron Cultured Cells	ES cell derived
38	chr17:45503200-45511800	Weak transcription	Primary hematopoietic stem cells G-CSF-mobilized Male	--
39	chr17:45503200-45512200	Weak transcription	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
40	chr17:45503200-45545400	Weak transcription	H9 Derived Neuronal Progenitor Cultured Cells	ES cell derived
41	chr17:45503400-45505600	Weak transcription	Dnd41	blood
42	chr17:45503600-45504800	Weak transcription	HepG2	liver
43	chr17:45503600-45509200	Weak transcription	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
44	chr17:45504600-45507400	Enhancers	Pancreatic Islets	Pancreatic Islet
45	chr17:45504800-45505000	Enhancers	Fetal Intestine Small	intestine
46	chr17:45504800-45505000	Enhancers	Rectal Mucosa Donor 29	rectum
47	chr17:45504800-45505600	Enhancers	Fetal Intestine Large	intestine
48	chr17:45504800-45505800	Enhancers	A549	lung
49	chr17:45504800-45507600	Enhancers	HepG2	liver
50	chr17:45505000-45505400	Weak transcription	Fetal Intestine Small	intestine

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links